Risk-Reducing Genetic Variant of Wilms Tumor 1 Gene rs16754 in Korean Patients With BCR-ABL1-Negative Myeloproliferative Neoplasm

The genetic variant rs16754 of Wilms tumor gene 1 (WT1) has recently been described as an independent prognostic factor in AML patients. It is of great interest to test whether WT1 single nucleotide polymorphism can be used as a molecular marker in other types of cancer, to improve risk and treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Namhee, Kim, In-Suk, Chang, Chulhun L., Kang, Jeong-Eun, Lee, Eun Yup, Shin, Ho-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2015
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390704/
https://www.ncbi.nlm.nih.gov/pubmed/25932444
http://dx.doi.org/10.3343/alm.2015.35.3.348

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390704/
https://www.ncbi.nlm.nih.gov/pubmed/25932444
http://dx.doi.org/10.3343/alm.2015.35.3.348

Ejemplares similares